U.S. market Closed. Opens in 16 hours 23 minutes

SGHT | Sight Sciences, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 4.46 - 4.77
52 Week Range 1.5750 - 8.45
Beta 2.72
Implied Volatility 149.77%
IV Rank 77.92%
Day's Volume 841,011
Average Volume 165,071
Shares Outstanding 50,307,300
Market Cap 234,432,018
Sector Healthcare
Industry Medical - Devices
IPO Date 2021-07-15
Valuation
Profitability
Growth
Health
P/E Ratio -4.40
Forward P/E Ratio N/A
EPS -1.06
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 214
Country USA
Website SGHT
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
*Chart delayed
Analyzing fundamentals for SGHT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see SGHT Fundamentals page.

Watching at SGHT technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SGHT Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙